Get the Stockscreener App
0.2637
1.50%
0.0039
After Hours:
.26
-0.0037
-1.40%
Fibrobiologics Inc stock is traded at $0.2637, with a volume of 1.48M.
It is up +1.50% in the last 24 hours and down -28.79% over the past month.
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
See More
Previous Close:
$0.2598
Open:
$0.252
24h Volume:
1.48M
Relative Volume:
1.36
Market Cap:
$16.16M
Revenue:
-
Net Income/Loss:
$-17.78M
P/E Ratio:
-0.4802
EPS:
-0.5492
Net Cash Flow:
$-10.52M
1W Performance:
-3.76%
1M Performance:
-28.79%
6M Performance:
-69.13%
1Y Performance:
-88.92%
1-Day Range:
$0.25
$0.2663
1-Week Range:
$0.24
$0.28
52-Week Range:
$0.24
$2.55
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics Inc
Sector
Industry
Phone
281-671-5150
Address
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.2637 | 15.94M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-24 | Initiated | H.C. Wainwright | Buy |
| Sep-24-24 | Initiated | Maxim Group | Buy |
Fibrobiologics Inc Stock (FBLG) Latest News
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser
FibroBiologics announces payoff of outstanding debt - MSN
Is FibroBiologics Inc. (SG0) stock good for long term investingQuarterly Growth Report & Technical Pattern Recognition Alerts - Newser
Is FibroBiologics Inc. stock dividend yield sustainableWeekly Trade Summary & Verified Momentum Watchlists - Newser
Is FibroBiologics Inc. (SG0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - Newser
Prepare Yourself for Liftoff: FibroBiologics Inc (FBLG) - Setenews
Reviewing FibroBiologics (NASDAQ:FBLG) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Will FibroBiologics Inc. stock gain from strong economyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - BỘ NỘI VỤ
FibroBiologics repays convertible notes, eliminating dilution risk By Investing.com - Investing.com Nigeria
FibroBiologics Announces Payoff of Outstanding Debt - The Manila Times
FibroBiologics repays convertible notes, eliminating dilution risk - Investing.com
FibroBiologics (Nasdaq: FBLG) retires $15M Yorkville notes, keeps access to $25M SEPA - Stock Titan
FibroBiologics closes $1.5 million registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics announces closing of $1.5 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com
FibroBiologics Closes $1.5 Million Registered Direct Share Offering - marketscreener.com
FibroBiologics closes $1.5 million registered direct offering - Investing.com
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
FibroBiologics Announces Securities Purchase Agreement - TipRanks
FibroBiologics raises $1.5 million in registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
FibroBiologics prices 4.48M shares at 33.5c in registered direct offering - TipRanks
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
FibroBiologics raises $1.5 million in registered direct offering - Investing.com
FibroBiologics (Nasdaq: FBLG) prices $1.5M direct offering at $0.335 with private warrants - Stock Titan
Will Naga Dhunseri Group Limited Stock Benefit From Industry Trends in YEARMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
FibroBiologics Inc Stock Analysis and ForecastHigh Yield Income Stocks & Capital Planning and Optimization - earlytimes.in
HC Wainwright & Co. Maintains FibroBiologics (FBLG) Buy Recommendation - MSN
Fibrobiologics receives Australian HREC approvals for CYWC-628 - BioWorld MedTech
FibroBiologics announces $25 million financing - MSN
Will FibroBiologics Inc. (SG0) stock outperform value peersJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
FibroBiologics (FBLG) Price Target Decreased by 14.63% to 8.92 - MSN
When is the best time to exit FibroBiologics Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
FibroBiologics prices 3.54M shares at 33c in registered direct offering - MSN
[424B5] FibroBiologics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
FibroBiologics (FBLG) Analyst Ratings: D. Boral Capital Maintains Buy | FBLG Stock News - GuruFocus
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - The Manila Times
Fibrobiologics receives HREC approval for phase 1/2 clinical trial for CYWC628 for the treatment of refractory diabetic foot ulcers - MarketScreener
FibroBiologics Receives HREC Approval for Phase 1/2 - GlobeNewswire
Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Oak Ridger
How FibroBiologics Inc. (SG0) stock trades in high volatilityEarnings Summary Report & Intraday High Probability Setup Alerts - newser.com
FibroBiologics closes $4 million registered direct offering By Investing.com - Investing.com Nigeria
FibroBiologics closes $4 million registered direct offering - Investing.com
Fibrobiologics Inc Stock (FBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):